Skip to main content
. 2022 Feb 21;28(6):865–870. doi: 10.1016/j.cmi.2022.02.014

Table 2.

Comparison of patients suspected of having COVID-19 assorted by the studied test

SGTI-Flex Panbio NovaGen
Cough 38% 41% 54%
Dyspnoea 7.5% 9% 15%
Headache 51.5% 49.5% 69%
Time since symptom onset (d), median (IQR) 2 (1–4) 3 (1–4) 2 (1–3)

Only variables with statistically significant differences are shown.